<DOC>
	<DOC>NCT00739635</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.</brief_summary>
	<brief_title>Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<criteria>Patients aged 18 to 75 years with a clinical diagnosis of first onset, Persistent (i.e. tinnitus should never be absent for &gt; 24 hours in a row), subjective, uni or bilateral tinnitus present for at least 3 months but not more than 12 months Clinical diagnosis of intermittent or pulsatile tinnitus Patients who have tinnitus as a concomitant symptom of an otological/neurological disease (such as otitis media, Meni√®re's disease, otosclerosis, etc)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>